Evidence map›Paper›PMID 31175550›Full record

ArticlePathology oncology research : POR2020

CUL1 Knockdown Attenuates the Adhesion, Invasion, and Migration of Triple-Negative Breast Cancer Cells via Inhibition of Epithelial-Mesenchymal Transition.

Ze-Qiang Ren, Wen-Jing Yan, Xiu-Zhong Zhang, Peng-Bo Zhang, Chong Zhang, Shou-Kun Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ze-Qiang RenGeneral Surgery of the Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, People's Republic of China. rzq0805@163.com.
Wen-Jing YanSchool of Nursing, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, 221004, People's Republic of China.
Xiu-Zhong ZhangGeneral Surgery of the Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, People's Republic of China.
Peng-Bo ZhangGeneral Surgery of the Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, People's Republic of China.
Chong ZhangGeneral Surgery of the Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, People's Republic of China.
Shou-Kun ChenGeneral Surgery of the Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, 221006, People's Republic of China.
Xuzhou Medical College · CN

Funding

the National Ministry of Health Project of China W201302
6 · The paper itself

Abstract

Cullin-1 (CUL1) is an important factor for tumor growth and a potential therapeutic target for breast cancer therapy, but the molecular mechanism in triple-negative breast cancer (TNBC) is unknown. In the present study, CUL1 shRNA was transfected into BT549 and MDA-MB-231 breast cancer cells. Cell morphology, adhesion, invasion, and migration assays were carried out in the CUL1 knockdown cells. Additionally, protein expression levels of epithelial-mesenchymal transition (EMT)-related factors, Akt phosphorylation at S473 (pAkt), glycogen synthase kinase-3β phosphorylation at ser9 (pGSK3β), cytoplasmic and nuclear β-catenin, and epidermal growth factor receptor phosphorylation at Tyr1068 (pEGFR) were detected by Western blot analysis. CUL1 knockdown significantly suppressed the adhesion, invasion and migration capabilities of the cells, and decreased the expression of Snail1/2, ZEB1/2, Twist1/2, Vimentin, and increased the expression of Cytokeratin 18 (CK18). Moreover, CUL1 knockdown significantly downregulated the phosphorylated levels of Akt, GSK3β, and EGFR, inhibiting the translocation of β-catenin from the cytoplasm to the nucleus. The results indicate that CUL1 knockdown prohibited the metastasis behaviors of breast cancer cells through downregulation (dephosphorylation) of the EMT signaling pathways of EGFR and Akt/GSK3β/β-catenin in breast cancer. These results strongly suggested that reinforcement of the EMT might be a key for CUL1 to accelerate TNBC metastasis.

Indexed as

Cell AdhesionCell Line, TumorCell MovementCullin ProteinsEpithelial-Mesenchymal TransitionFemaleGene Knockdown TechniquesHumansNeoplasm InvasivenessTriple Negative Breast NeoplasmsCullin 1Cullin ProteinsAktBreast CancerCUL1EGFREpithelial-mesenchymal transitionGSK3β

Identifiers

PMID31175550
OpenAlexW2957705340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.